{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Orlando",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90204",
      "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy",
      "address_1": "6700 Conroy Rd Ste 155",
      "address_2": "",
      "postal_code": "32835-3515",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands",
      "recall_number": "D-0939-2022",
      "product_description": "NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Rx Only, Olympia Pharmaceuticals,  6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0083-00.",
      "product_quantity": "8982 vials",
      "reason_for_recall": "Lack of assurance of sterility.",
      "recall_initiation_date": "20220509",
      "center_classification_date": "20220525",
      "report_date": "20220601",
      "code_info": "Lots: A2401422 BUD: 1/14/2023, K41001 BUD: 11/1/2022, K41130 BUD: 11/30/2022, L24113 BUD: 12/13/2022, L41102 BUD: 12/2/2022",
      "more_code_info": ""
    }
  ]
}